GEODE CAPITAL MANAGEMENT, LLC - CATALYST BIOSCIENCES INC ownership

CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 37 filers reported holding CATALYST BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of CATALYST BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$124,818
+31.5%
258,746
-4.2%
0.00%
Q2 2023$94,943
+69.9%
270,0330.0%0.00%
Q1 2023$55,896
+38716.7%
270,033
-1.7%
0.00%
Q4 2022$144
-99.9%
274,587
-0.2%
0.00%
Q3 2022$138,000
-71.8%
275,2650.0%0.00%
Q2 2022$489,000
+148.2%
275,265
-8.0%
0.00%
Q1 2022$197,000
-24.5%
299,201
+4.4%
0.00%
Q4 2021$261,000
-81.9%
286,585
-18.5%
0.00%
Q3 2021$1,444,000
+0.3%
351,541
+5.7%
0.00%
Q2 2021$1,439,000
-46.6%
332,479
-37.8%
0.00%
Q1 2021$2,693,000
+34.5%
534,372
+68.4%
0.00%
Q4 2020$2,002,000
+62.9%
317,326
+10.9%
0.00%
Q3 2020$1,229,000
-13.6%
286,017
+18.0%
0.00%
Q2 2020$1,422,000
+174.5%
242,405
+104.3%
0.00%
Q1 2020$518,000
-64.3%
118,668
-44.3%
0.00%
Q4 2019$1,450,000
+177.2%
213,184
+100.0%
0.00%
Q3 2019$523,000
-23.5%
106,592
+14.7%
0.00%
Q2 2019$684,000
-38.8%
92,892
-32.6%
0.00%
Q1 2019$1,118,000
-50.8%
137,874
-52.2%
0.00%
Q4 2018$2,274,000
+52.1%
288,350
+107.8%
0.00%
Q3 2018$1,495,000
-23.3%
138,770
-16.9%
0.00%
-100.0%
Q2 2018$1,948,000
+20.3%
166,932
+165.9%
0.00%0.0%
Q1 2018$1,619,000
+327.2%
62,775
+125.8%
0.00%
Q4 2017$379,000
+564.9%
27,803
+123.6%
0.00%
Q2 2017$57,00012,4320.00%
Other shareholders
CATALYST BIOSCIENCES INC shareholders Q4 2022
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 3,076,376$13,321,0006.97%
22NW, LP 1,429,242$6,189,0001.66%
Ghost Tree Capital, LLC 1,000,000$4,330,0001.19%
ACUTA CAPITAL PARTNERS, LLC 685,000$2,966,0001.18%
Sio Capital Management, LLC 623,892$2,701,0000.67%
Parkman Healthcare Partners LLC 393,449$1,704,0000.37%
Nantahala Capital Management 2,531,360$10,961,0000.31%
AlphaCentric Advisors LLC 182,500$790,0000.22%
Ikarian Capital, LLC 581,200$2,518,0000.20%
Tibra Equities Europe Ltd 79,200$343,0000.11%
View complete list of CATALYST BIOSCIENCES INC shareholders